These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 34758691)

  • 21. SALL4 is a marker of poor prognosis in serous ovarian carcinoma promoting invasion and metastasis.
    Yang M; Xie X; Ding Y
    Oncol Rep; 2016 Mar; 35(3):1796-806. PubMed ID: 26750614
    [TBL] [Abstract][Full Text] [Related]  

  • 22. miR-96-5p promotes the proliferation and migration of ovarian cancer cells by suppressing Caveolae1.
    Liu B; Zhang J; Yang D
    J Ovarian Res; 2019 Jun; 12(1):57. PubMed ID: 31228941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospective pathway signaling and prognostic values of MicroRNA-9 in ovarian cancer based on gene expression omnibus (GEO): a bioinformatics analysis.
    Zuo L; Li X; Tan Y; Zhu H; Xiao M
    J Ovarian Res; 2021 Feb; 14(1):29. PubMed ID: 33563317
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of Multimerin 1 (MMRN1) expression in ovarian cancer.
    Saini A; Chandra KB; Kumar V; Mathur SR; Sharma JB; Kumar S; Yadav S
    Mol Biol Rep; 2020 Dec; 47(12):9459-9468. PubMed ID: 33263168
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic biomarkers in ovarian cancer.
    Huang J; Hu W; Sood AK
    Cancer Biomark; 2010-2011; 8(4-5):231-51. PubMed ID: 22045356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advances in the role of GPX3 in ovarian cancer (Review).
    Geng D; Zhou Y; Wang M
    Int J Oncol; 2024 Mar; 64(3):. PubMed ID: 38299269
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Expression and significance of PD-1 and PD-L1 in the specimens of epithelial ovarian cancer].
    Ju C; Gao JC; Zhang PX; Zhang KN; Yang S; Kang TJ; Zhao HZ; Qi WJ; Zhang QP; Kong FD; Guan HW; Shi H
    Zhonghua Fu Chan Ke Za Zhi; 2020 Aug; 55(8):529-534. PubMed ID: 32854477
    [No Abstract]   [Full Text] [Related]  

  • 28. Multi-omics analysis of tumor mutational burden combined with prognostic assessment in epithelial ovarian cancer based on TCGA database.
    Liu J; Xu W; Li S; Sun R; Cheng W
    Int J Med Sci; 2020; 17(18):3200-3213. PubMed ID: 33173439
    [No Abstract]   [Full Text] [Related]  

  • 29. Identification of pathological grade and prognosis-associated lncRNA for ovarian cancer.
    Chen Y; Bi F; An Y; Yang Q
    J Cell Biochem; 2019 Sep; 120(9):14444-14454. PubMed ID: 31034644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circular RNAs and their emerging roles as diagnostic and prognostic biomarkers in ovarian cancer.
    Sheng R; Li X; Wang Z; Wang X
    Cancer Lett; 2020 Mar; 473():139-147. PubMed ID: 31904484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long non-coding RNA GAS5 inhibits DDP-resistance and tumor progression of epithelial ovarian cancer via GAS5-E2F4-PARP1-MAPK axis.
    Long X; Song K; Hu H; Tian Q; Wang W; Dong Q; Yin X; Di W
    J Exp Clin Cancer Res; 2019 Aug; 38(1):345. PubMed ID: 31391118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of key molecular markers in epithelial ovarian cancer by integrated bioinformatics analysis.
    Qin W; Yuan Q; Liu Y; Zeng Y; Ke D; Dai X; Shuai Y; Hu J; Shi H
    Taiwan J Obstet Gynecol; 2021 Nov; 60(6):983-994. PubMed ID: 34794761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel risk score system for assessment of ovarian cancer based on co-expression network analysis and expression level of five lncRNAs.
    Zhao Q; Fan C
    BMC Med Genet; 2019 Jun; 20(1):103. PubMed ID: 31182053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of aberrant methylation of HOXA9 and HIC1 through multiplex MethyLight assay in serum DNA for the early detection of epithelial ovarian cancer.
    Singh A; Gupta S; Badarukhiya JA; Sachan M
    Int J Cancer; 2020 Sep; 147(6):1740-1752. PubMed ID: 32191343
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comprehensive methylome analysis of ovarian tumors reveals hedgehog signaling pathway regulators as prognostic DNA methylation biomarkers.
    Huang RL; Gu F; Kirma NB; Ruan J; Chen CL; Wang HC; Liao YP; Chang CC; Yu MH; Pilrose JM; Thompson IM; Huang HC; Huang TH; Lai HC; Nephew KP
    Epigenetics; 2013 Jun; 8(6):624-34. PubMed ID: 23774800
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression and Clinical Significance of Microtubule-Actin Cross-Linking Factor 1 in Serous Ovarian Cancer.
    Liu L; Hu K; Zeng Z; Xu C; Lv J; Lin Z; Wen B
    Recent Pat Anticancer Drug Discov; 2021; 16(1):66-72. PubMed ID: 33573562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long non-coding RNAs: A view to kill ovarian cancer.
    Zamaraev AV; Volik PI; Sukhikh GT; Kopeina GS; Zhivotovsky B
    Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188584. PubMed ID: 34157315
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR-205-3p Functions as a Tumor Suppressor in Ovarian Carcinoma.
    Qiao B; Wang Q; Zhao Y; Wu J
    Reprod Sci; 2020 Jan; 27(1):380-388. PubMed ID: 32046433
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Engrailed-2 (EN2) - a novel biomarker in epithelial ovarian cancer.
    McGrath SE; Annels N; Madhuri TK; Tailor A; Butler-Manuel SA; Morgan R; Pandha H; Michael A
    BMC Cancer; 2018 Oct; 18(1):943. PubMed ID: 30285763
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The emerging roles and therapeutic potential of exosomes in epithelial ovarian cancer.
    Li X; Wang X
    Mol Cancer; 2017 May; 16(1):92. PubMed ID: 28506269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.